Sienna Biopharmaceuticals, Inc. Total Assets
Sienna Biopharmaceuticals, Inc. had Total Assets of $43.49 million as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2019-11-12
- 2019-09-30: Assets $43.49M.
- 2019-06-30: Assets $107.63M.
- 2019-03-31: Assets $115.05M.
- 2018-12-31: Assets $107.31M.
| Period end | Assets |
|---|---|
| 2019-09-30 | $43.49M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $107.63M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $115.05M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $107.31M 10-Q · filed 2019-11-12 |
| 2018-09-30 | $124.63M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $135.72M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $123.54M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $136.85M 10-K · filed 2019-03-14 |
| 2017-09-30 | $149.45M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $92.00M 10-Q · filed 2017-09-07 |
| 2016-12-31 | $62.38M 10-K · filed 2018-03-15 |